본문영역
-
Hospital
If your elementary school child’s hair smells, it could be a sign of 'sexual precocity'
If your daughter or son, barely eight or nine years of age, starts to smell in their hair, there's a condition you should strongly suspect -- precocious puberty -- a condition that...
Kim Kyoung-Won
2024-04-26 4:49 PM
-
Bio
Artiva Biotherapeutics appoints new executives to boost strategic growth
GC Cell said its U.S. affiliate, Artiva Biotherapeutics, has appointed two new executives to its leadership team in a strategic move to bolster its future growth and operational ef...
Lee Han-soo
2024-04-26 2:26 PM
-
Pharma
Korea United Pharm, UNS Bio, and Y-Biologics to develop new ADC anticancer drug
Korea United Pharm and UNS Bio said Friday that they had signed a memorandum of understanding with Y-Biologics to develop new antibody-drug conjugate (ADC) anticancer drugs.Through...
Yang Hyeon-su
2024-04-26 3:52 PM
-
Device/ICT
Lunit announces convertible bond issuance to finance Volpara Health acquisition
Lunit, a Korean medical AI company, disclosed plans to acquire all shares of Volpara Health Technologies, a New Zealand-based firm specializing in breast imaging AI solutions.To fu...
Lee Han-soo
2024-04-26 3:40 PM
-
Opinion
[Column] Does the apple cider vinegar diet work?
The apple cider vinegar diet is regaining popularity. Apple cider vinegar is crafted through the fermentation of cider (apple cider). Initially, when apple juice undergoes fermenta...
Jeong Jae-hoon
2024-04-26 1:21 PM
-
Pharma
Galderma Korea to launch ‘Restylane Eyelight’ in June
Galderma Korea said Friday that it will launch “Restylane Eyelight,” a new product of its premium hyaluronic acid filler brand Restylane, in June in Korea.Restylane Eyelight featur...
Kim Chan-hyuk
2024-04-26 3:49 PM
-
Hospital
JYP Entertainment donates ₩500 million to YUHS to support underprivileged children
JYP Entertainment has donated 500 million won ($362,792) to Yonsei University Health System (YUHS) to support the treatment costs for underprivileged children.The generous funds fr...
Lee Han-soo
2024-04-26 1:12 PM
-
Pharma
Is OliX Pharmaceuticals’ release of phase 2 results of OLX101A a half success?
OliX Pharmaceuticals’ short interfering ribonucleic acid (siRNA)-based hypertrophic scar treatment OLX10010 (OLX101A) has raised questions in the market due to the omission of cert...
Kim Chan-hyuk
2024-04-26 1:08 PM
-
Pharma
Imfinzi-Imjudo dual immunotherapy offers new option for 1st-line treatment of liver...
As AstraZeneca launches Imjudo (tremelimumab) without health insurance coverage in May, Korean liver cancer patients will likely have another immunotherapy option for first-line sy...
Kim Yun-mi
2024-04-26 11:45 AM
-
Bio
Samsung Biologics' Q1 sales, operating income hit record high
Samsung Biologics achieved a record-breaking earnings performance in the first quarter of 2024, reporting the highest-ever quarterly revenue and operating profit, thanks to increas...
Lee Han-soo
2024-04-25 4:53 PM
-
Pharma
Celltrion-incubated startups move into Seoul Biohub
Biotech startups supported by Celltrion through its “open innovation strategy” are nesting in Seoul Biohub.Celltrion said Thursday that it attended the Seoul Biohub Global Center o...
Kim Chan-hyuk
2024-04-25 3:40 PM
-
Hospital
Hemorrhagic cystitis could occur in prostate cancer patients 1 year after radiotherapy...
In 5 to 10 percent of patients who receive radiation therapy for prostate cancer, there is a side effect that can show up months to years later -- hemorrhagic cystitis. Why does th...
Kim Kyoung-Won
2024-04-25 3:26 PM
-
Pharma
LG Chem partners with EuBiologics to develop pediatric vaccine against 6 diseases
LG Chem has announced a partnership with EuBiologics to enhance the domestic production capabilities of pediatric vaccines in Korea.The collaboration focuses on developing the hexa...
Lee Han-soo
2024-04-25 3:15 PM
-
Hospital
University hospitals in crisis: senior doctors resign amid burnout, financial woes deepen
The agony of university hospital heads is deepening as medical professors who complained of “burnout” announced their resignation on Thursday following the shortened medical treatm...
Kim Eun-young
2024-04-25 1:06 PM
-
Pharma
Entresto builds clinical evidence for 'heart failure with ejection fraction...
Novartis' angiotensin receptor-neprilysin inhibitor (ARNI) heart failure treatment Entresto (sacubitril/valsartan) has reduced hospitalization rates in patients with newly diagnose...
Kim Chan-hyuk
2024-04-25 2:48 PM
-
Device/ICT
Ybrain and Meditrix to collaborate on mind health digital devices
Ybrain said it has signed a memorandum of understanding (MOU) with Meditrix, a digital medical device company, to collaborate on developing a digital treatment device for depressio...
Yang Hyeon-su
2024-04-25 1:00 PM
-
Device/ICT
VUNO's AI-based ophthalmic diagnostic SW receives key regulatory approval
VUNO said its AI-based retinal imaging diagnostic support solution, VUNOMED Fundus AI, has received approval from the Ministry of Food and Drug Safety (MFDS) for an integrated revi...
Lee Han-soo
2024-04-25 1:02 PM
-
Device/ICT
Noul releases malaria diagnostics study result in Africa
Noul, an AI-based blood and cancer diagnostic platform company, said it presented the results of a clinical performance study of its malaria diagnostic solution at an African confe...
Yang Hyeon-su
2024-04-25 11:44 AM
-
Device/ICT
Macrogen breaks ground for ‘Asia’s largest genome big data hub’
Macrogen, a Korean digital healthcare company, said it held a groundbreaking ceremony for the Songdo Global Genome Center in Incheon. The company emphasizes that this facility is A...
Kim Yoon-mi
2024-04-25 10:32 AM
-
Pharma
Moderna, Yonsei University collaborate on mRNA education to foster experts
Moderna and the Korean National Institute for Bioprocessing Research and Training (K-NIBRT) at Yonsei University have signed an agreement to develop mRNA education content and prog...
Korea Biomedical Review
2024-04-25 11:04 AM
-
Device/ICT
Lunit to release 7 AI biomarker platform-based study abstracts at ASCO 2024
Medical AI company Lunit said Thursday that it would present seven research studies using its AI biomarker platform, “Lunit SCOPE,” at the 2024 American Society of Clinical Oncolog...
Korea Biomedical Review
2024-04-25 10:45 AM
-
Pharma
Jeil Pharma’s subsidiary receives approval for Korea’s 37th novel drug to treat GERD
Onconic Therapeutics, a subsidiary of Jeil Pharma Holdings, said it received approval from the Ministry of Food and Drug Safety for Jaqbo (ingredient: Zastaprazan), a drug for the ...
Lee Han-soo
2024-04-25 10:22 AM
-
Hospital
SNUH to suspend all treatments next Tuesday as senior doctors leave hospital
Professor Bang Jae-seung, chairman of the emergency committee of the Seoul National University College of Medicine and Seoul National University Hospital (SNUH) faculty council, wi...
Koh Jung Min
2024-04-24 3:37 PM
-
Pharma
Viatris celebrates Lipitor's vital role in dyslipidemia control, CVD prevention in Korea
Viatris Korea celebrated 25 years of Lipitor (atorvastatin) sales in Korea, highlighting its pivotal role in dyslipidemia treatment and cardiovascular diseases (CVD) prevention at ...
Lee Han-soo
2024-04-24 3:05 PM
-
Pharma
Fexuclue sales soar 57% in Q1, boosting Daewoong's GERD market growth
Daewoong Pharmaceutical said Thursday that Fexuclue's prescription sales grew 57 percent year over year to 17 billion won ($12.4 million) in the first quarter of this year.Accordin...
Yang Hyeon-su
2024-04-24 4:22 PM
-
Hospital
New research offers hope in multiple myeloma treatment through enhanced NK...
Severance Hospital researchers have identified a promising method to rejuvenate the effectiveness of natural killer cells in combating multiple myeloma, a serious form of blood can...
Lee Han-soo
2024-04-24 5:06 PM
-
Policy
RIGHT Foundation opens grants for global health equity in infectious disease
The Research Investment for Global Health Technology Foundation, commonly known as the RIGHT Foundation, said it opened its grant application aimed at significantly enhancing healt...
Lee Han-soo
2024-04-24 4:08 PM
-
Device/ICT
VUNO introduces cardiac arrest risk monitoring device at critical care society’s meet
VUNO will exhibit its AI-powered cardiac arrest risk monitoring device, VUNO Med-DeepCARS, at the 44th Korean Society of Critical Care Medicine (KSCCM) Annual Congress-Acute and Cr...
Yang Hyeon-su
2024-04-24 4:01 PM
-
Hospital
This pediatrician found greatest reward in children’s laughs but the government...
"We are very sorry that we will be unable to be by your side."That's what the Department of Pediatric Nephrology professors at Seoul National University Hospital (SNUH) wrote in a ...
Kim Ju-yeon
2024-04-24 1:46 PM
-
Pharma
Darzalex’s reimbursement has been in limbo for 3 years. Will it be different this time?
Attention is drawn to whether the reimbursement criteria for the multiple myeloma drug Darzalex (daratumumab), unchanged since May 2021, will be expanded for the first time in thre...
Kim Yun-mi
2024-04-24 11:38 AM
-
Pharma
Chong Kun Dang signs licensing deal for Curigin's bladder cancer gene therapy
Chong Kun Dang said it has entered into a licensing agreement with Curigin, a local gene therapy developer, for the latter's CA102, a gene therapy candidate targeting superficial b...
Lee Han-soo
2024-04-24 1:47 PM
-
Hospital
Major hospitals in Seoul to protest government policy with weekly day off
Senior physicians at Seoul National University Hospital (SNUH) and Asan Medical Center (AMC) said they decided to refuse surgery and outpatient care by taking a day off every week ...
Kim Eun-young
2024-04-24 9:51 AM
-
Pharma
Hanmi Pharm partners with MSD for clinical trial of cancer therapy BH3120
Hanmi Pharmaceutical said it has entered into a clinical trial collaboration and supply agreement (CTCSA) with Merck & Co., Inc., known as MSD outside the U.S. and Canada.The partn...
Lee Han-soo
2024-04-23 5:20 PM
-
Bio
Samsung Bioepis gains European approval for Stelara biosimilar
Samsung Bioepis said it has secured final product approval from the European Commission (EC) for its latest biosimilar, Pyzchiva, also known as SB17, a biosimilar candidate referen...
Lee Han-soo
2024-04-23 4:04 PM
-
Device/ICT
Medical AI companies begin to supply homegrown solutions
AI solutions developed by Korean medical artificial intelligence companies, including Lunit, have begun to be used in medical sites, raising expectations among market players and t...
Kim Chan-hyuk
2024-04-23 12:43 PM
-
Policy
Despite government’s refusal to accept resignation, medical professors ‘quietly’...
A top government official recently said that professors at even private medical schools, let alone national ones, are subject to the National Civil Service Act, raising the possibi...
Kwak Sung-sun
2024-04-23 4:02 PM
-
Pharma
GC Biopharma applies for US approval of Sanfilippo Syndrome treatment
GC Biopharma said it has submitted an investigational new drug (IND) application and applied for Fast Track Designation with the U.S. FDA for GC1130A, an intracerebroventricular (I...
Lee Han-soo
2024-04-23 3:02 PM
-
Pharma
Pharos iBio and MEDiC to collaborate on new drug research
Pharos iBio said it has signed a memorandum of understanding with MEDiC Life Sciences, a Silicon Valley-based company that has established a gene-scissor technology (CRISPR) based ...
Yang Hyeon-su
2024-04-23 4:54 PM
-
Pharma
Curocell applies for expedited approval of CAR-T therapy
Curocell, a chimeric antigen receptor-T (CAR-T) developer, has applied for Anbal-cel, its CAR-T candidate, to be included in the Ministry of Food and Drug Safety (MFDS)’s Advanced ...
Lee Han-soo
2024-04-23 11:00 AM
-
Bio
Jung Kwan Jang hosts seminar on red ginseng at US conference
Jung Kwan Jang, Korea’s top ginseng product manufacturer, said it conducted a seminar focused on the efficacy and safety of red ginseng during the International Conference on the S...
Lee Han-soo
2024-04-23 3:02 PM
-
Pharma
Celltrion's Remsima attains 74% market share in 5 key European countries
Celltrion's Remsima (infliximab) line of products continues to demonstrate market impact with expanded prescriptions in five major European countries—the U.K., Germany, France, Spa...
Korea Biomedical Review
2024-04-23 11:51 AM
-
Device/ICT
Kakao Healthcare and OURHOME to research and develop AI-based…
Kakao Healthcare said Tuesday that it has signed a business agreement with global food care and catering company OURHOME to develop AI-based ultra-personalized healthcare solutions...
Korea Biomedical Review
2024-04-23 11:01 AM
-
Pharma
HK inno.N’s GERD drug K-CAB advances to Middle East, North Africa
HK inno.N's GERD drug K-CAB has expanded its momentum to the Middle East and North Africa region.Starting from China and expanding across Asia and North and South America, K-CAB is...
Korea Biomedical Review
2024-04-23 11:50 AM
-
Device/ICT
Deep Bio's prostate cancer diagnosis software aims to enter US…
The importance of early diagnosis of prostate cancer cannot be overstated. According to data from the World Cancer Research Fund International, prostate cancer is the second most c...
Lee Han-soo
2024-04-22 3:13 PM
-
Pharma
MBK Partners to buy pharma distributor Geo-Young for nearly ₩2 trillion: report
Korea's largest private equity firm, MBK Partners, has agreed to purchase a majority stake in Geo-Young, the nation's top pharmaceutical distributor, from Blackstone for approximat...
Lee Han-soo
2024-04-22 4:17 PM
-
Pharma
Palmoplantar pustulosis patients pin hope on Skyrizi’s approval
Skyrizi (risankizumab) has emerged as a new option for treating palmoplantar pustulosis (PPP), a condition characterized by pustules, exfoliation, and red patches on the palms of t...
Kim Chan-hyuk
2024-04-22 4:38 PM
-
Pharma
Bayer Korea launches plogging campaign to celebrate Earth Day
In alignment with Earth Day, an annual event on April 22, Bayer Korea began its annual "Glück for Green" plogging campaign, an initiative designed to foster sustainable practices a...
Lee Han-soo
2024-04-22 5:01 PM
-
Device/ICT
Canon Medical installs AI-backed low-dose radiation CT simulation at Yeungnam...
Canon Medical Systems Korea said it installed Aquilion Exceed LB, a state-of-the-art low-dose radiation CT (computed tomography) simulation machine, at Yeungnam University Medical ...
Korea Biomedical Review
2024-04-22 2:42 PM
-
Device/ICT
Plasmapp to supply plasma sterilizer to Osstem Implant
Plasmapp, a bioplasma deep-tech company, said Monday that it had signed a contract to supply plasma sterilizers to Osstem Implant.Following signing contracts with large global dist...
Korea Biomedical Review
2024-04-22 2:57 PM
-
Device/ICT
Boston Scientific launches intragastric appetite suppression balloon 'BIB System' with coverage
Boston Scientific said Monday that it has released the BIB System, a balloon for suppressing appetite in the stomach that can help obese patients lose weight, with insurance covera...
Korea Biomedical Review
2024-04-22 3:20 PM